Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer
Clinical trial NCT00183937 · TERMINATED
Trial details
- NCT number
- NCT00183937
- Sponsor
- University of Southern California
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-30
- Primary completion
- 2010-10-23
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.